(Q37134884)

18 August 2017

Mesothelin, a novel immunotherapy target for triple negative breast cancer (English)

1 reference

18 August 2017

1 reference

1 reference

10

Carl H June

1 reference

18 August 2017

6

Hossein Borghaei

1 reference

18 August 2017

Julia Tchou

1

1 reference

18 August 2017

Liang-Chuan Wang

2

1 reference

18 August 2017

Ben Selven

3

1 reference

18 August 2017

Hongtao Zhang

4

1 reference

18 August 2017

Jose Conejo-Garcia

5

1 reference

18 August 2017

Michael Kalos

7

1 reference

18 August 2017

Robert H Vondeheide

8

1 reference

18 August 2017

Steven M Albelda

9

1 reference

18 August 2017

Paul J Zhang

11

1 reference

18 August 2017

language of work or name

English

0 references

publication date

15 March 2012

1 reference

Breast Cancer Research and Treatment

18 August 2017

1 reference

18 August 2017

133

1 reference

18 August 2017

2

1 reference

18 August 2017

799-804

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Metastatic behavior of breast cancer subtypes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Basal-like breast cancer: a critical review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Mesothelin targeted cancer immunotherapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Monoclonal Antibody K1 Reacts With Epithelial Mesothelioma but not With Lung Adenocarcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Value of mesothelin immunostaining in the diagnosis of mesothelioma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964602

Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-012-2018-4

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-012-2018-4

Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22418702

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-012-2018-4

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

22418702

1 reference